<scp>CD</scp>34<sup>+</sup> cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis
Tõru Nakamura, Michio Sata(Kurume University), Seiya Okuda(Kurume University), Masahiro Sakata(The University of Osaka), Takashi Okamura(Kwansei Gakuin University), Atsuhiko Kawamoto(Northwestern University), Yukie Hori(Kurume University Hospital), Takato Ueno(Kurume University), Yu Ikezono(Kurume University), Jyunichi Kurogi(Kurume University), Takuji Torimura(Omuta hospital), Masaaki Ii(Foundation for Biomedical Research and Innovation), Takayuki Asahara(Shonan Kamakura General Hospital), Hideki Iwamoto, Osamu Hashimoto(Gifu University), Nobuyoshi Fukushima(Nagasaki Medical Center), Shuji Sumie(Kurume University), Hiroto Inoue(Okayama University), Kazuhiko Oho(Yanagawa Rehabilitation Hospital), Mitsuhiko Abe(Kurume University), Hironori Koga(Kurume University)
Cited by 25
Related Papers
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
|Journal of Clinical Investigation|1999|770
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
|Journal of Clinical Investigation|2001|651
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
|Journal of Hepatology|1997|614
HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cells
|Journal of Clinical Investigation|2001|609